Spectrum Pharmaceuticals reported $0 in Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Actinium Pharmaceuticals ATNM:US $ 110K 21K
Agios Pharmaceuticals AGIO:US $ 1.01M 0.44M
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Amgen AMGN:US $ 32782M 97M
Arrowhead Research ARWR:US $ 0M 0M
Astellas Pharma 4503:JP Y 348855M 1671M
AstraZeneca AZN:LN 27495M 7363M
Bayer BAYN:GR € 40372M 2493M
Biogen BIIB:US $ 7269.2M 2M
Bristol Myers Squibb BMY:US $ 45158M 1124M
Coherus Biosciences CHRS:US $ 406.09M 0.44M
Eli Lilly And LLY:US $ 16515.1M 310.6M
Endo International Ordinary Shares ENDP:US $ 8304.11M 3.58M
GlaxoSmithKline GSK:LN 25483M 736M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Karyopharm Therapeutics KPTI:US $ 301.38M 59.58M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 35769M 2030M
Puma Biotechnology PBYI:US $ 100.14M 0.93M
Seattle Genetics SGEN:US $ 0M 0M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Takeda 4502:JP Y 4405861M 4383708M
Teva Pharmaceutical TEVA:IT 25.13B 147M
YTE INCY:US $ 34.25M 0.22M